Christopher J. Rivard

9.5k citations

133 papers · 6.7k indexed · 2 hit papers · h-index 42

Impact in

Nephrology top 0.5%
- Gout, Hyperuricemia, Uric Acid
Endocrinology, Diabetes and Metabolism top 1%
- Diet, Metabolism, and Disease

Papers in

Nephrology 19
Building and Construction 17
- Anaerobic Digestion and Biogas Production 17

Co-authors: Richard J. Johnson Miguel A. Lanaspa Carlos A. Roncal-Jiménez Laura Gabriela Sánchez‐Lozada Christina Cicerchi Tomás Berl Takuji IshimotoHui Yu
Journals: Applied Biochemistry and Biotechnology (17 papers)Journal of Thoracic Oncology (14 papers)American Journal of Physiology-Renal Physiology (8 papers)PLoS ONE (6 papers)Proceedings of the National Academy of Sciences (5 papers)
Partner nations: United States Japan China

In The Last Decade

Christopher J. Rivard

129 papers receiving 6.5k citations

Hit Papers

align trajectories log scale

A Prospective, Multi-institutional, Pathologist-Based Assessment of 4 Immunohistochemistry Assays for PD-L1 Expression in Non–Small Cell Lung Cancer 2017 · 576 citations

Peers

Countries citing papers authored by Christopher J. Rivard

Since Specialization

Citations

This map shows the geographic impact of Christopher J. Rivard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher J. Rivard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher J. Rivard more than expected).

Fields of papers citing papers by Christopher J. Rivard

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher J. Rivard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher J. Rivard. The network helps show where Christopher J. Rivard may publish in the future.

Co-authors

The 25 scholars most cited alongside Christopher J. Rivard, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Christopher J. Rivard Line = papers co-authored together Christopher J. Rivard links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Characterization of Tumor-Associated Macrophages and the Immune Microenvironment in Limited-Stage Neuroendocrine-High and -Low Small Cell Lung Cancer Biology ·Dávid Dóra, Christopher J. Rivard, Hui Yu, Noriaki Yabe, Viktória László, Keila Tomoko Higa Taniguchi, Zsolt Megyesfalvi, Elek Dinya, Lai Shirong, L. Maccarone, Fred R. Hirsch, Balázs Döme, Zoltán Lohinai	2021	27
2	FGFR1 Is Critical for RBL2 Loss–Driven Tumor Development and Requires PLCG1 Activation for Continued Growth of Small Cell Lung Cancer Cancer Research ·Kee‐Beom Kim, Youngchul Kim, Christopher J. Rivard, Dong‐Wook Kim, (unknown)	2020	25
3	Comprehensive Immune Profiling of Medullary Thyroid Cancer Thyroid ·Nikita Pozdeyev, Timothy A. Erickson, Lian Zhang, Kim Ellison, Christopher J. Rivard, Sharon B. Sams, Fred R. Hirsch, Bryan R. Haugen, Jena D. French	2020	39
4	Role of mTOR As an Essential Kinase in SCLC Journal of Thoracic Oncology ·Jeffrey A. Kern, Jihye Kim, Daniel G. Foster, Rangnath Mishra, Eric E. Gardner, John T. Poirier, Christopher J. Rivard, Hui Yu, James H. Finigan, Afshin Dowlati, Charles M. Rudin, Aik Choon Tan	2020	16
5	P1.12-05 Microenvironment Characterization of Small Cell Lung Cancer Xenografts Implanted in Hematopoietic Humanized Mice Journal of Thoracic Oncology ·Hui Yu, Julie Lang, Jeffrey A. Kern, Noriaki Yabe, Charles M. Rudin, Christopher J. Rivard, Fred R. Hirsch	2019	2
6	CD44 Facilitates Epithelial-to-Mesenchymal Transition Phenotypic Change at Acquisition of Resistance to EGFR Kinase Inhibitors in Lung Cancer Molecular Cancer Therapeutics ·Kenichi Suda, Isao Murakami, Hui Yu, Jihye Kim, Aik Choon Tan, Hiroshi Mizuuchi, Leslie Rozeboom, Kim Ellison, Christopher J. Rivard, Tetsuya Mitsudomi, Fred R. Hirsch	2018	39
7	Innate Genetic Evolution of Lung Cancers and Spatial Heterogeneity: Analysis of Treatment-Naïve Lesions Journal of Thoracic Oncology ·Kenichi Suda, Jihye Kim, Isao Murakami, Leslie Rozeboom, Masaki Shimoji, Shigeki Shimizu, Christopher J. Rivard, Tetsuya Mitsudomi, Aik Choon Tan, Fred R. Hirsch	2018	21
8	EGFR Gene Copy Number by FISH May Predict Outcome of Necitumumab in Squamous Lung Carcinomas: Analysis from the SQUIRE Study Journal of Thoracic Oncology ·Carlo Genova, Mark A. Socinski, Rebecca R. Hozak, Gu Mi, Raffael Kurek, Javad Shahidi, Luis Paz‐Ares, Nick Thatcher, Christopher J. Rivard, Пшеничникова Галина Николаевна, Fred R. Hirsch	2017	10
9	Therapy-induced E-cadherin downregulation alters expression of programmed death ligand-1 in lung cancer cells Lung Cancer ·Kenichi Suda, Leslie Rozeboom, Christopher J. Rivard, Hui Yu, Kim Ellison, Mary Ann Melnick, Trista K. Hinz, Daniel C. Chan, Lynn E. Heasley, Katerina Politi, Tetsuya Mitsudomi, Fred R. Hirsch	2017	26
10	Heat stress, hydration and uric acid: a cross-sectional study in workers of three occupations in a hotspot of Mesoamerican nephropathy in Nicaragua BMJ Open ·Catharina Wesseling, Aurora Aragón, Marvin González-Quiroz, Ilana Weiss, Jason Glaser, Christopher J. Rivard, Carlos A. Roncal-Jiménez, Ricardo Correa‐Rotter, Richard J. Johnson	2016	128
11	PS01.20: Immune Checkpoints Expression in Small Cell Lung Cancer Lines Journal of Thoracic Oncology ·Hui Yu, Yayi He, Christopher J. Rivard, Dan Chan, Dexiang Gao, Kim Ellison, Yahya Doğan, Kenichi Suda, Fred R. Hirsch	2016	1
12	MHC class II in lung cancer Annals of Oncology ·Yayi He, Yahya Doğan, Rafał Dziadziuszko, Christopher J. Rivard, Kimberly Ellison, Hui Yu, Caicun Zhou, Fred R. Hirsch	2016	0
13	Serum uric acid and insulin sensitivity in adolescents and adults with and without type 1 diabetes Journal of Diabetes and its Complications ·Petter Bjornstad, Janet K. Snell‐Bergeon, Kimberly K. McFann, R. Paul Wadwa, Marian Rewers, Christopher J. Rivard, Diana Jalal, Michel B. Chonchol, Richard J. Johnson, David M. Maahs	2014	29
14	Fructokinase activity mediates dehydration-induced renal injury Kidney International ·Michał Kuc, Takuji Ishimoto, Miguel A. Lanaspa, Christopher J. Rivard, Takahiko Nakagawa, A. Ahsan Ejaz, Christina Cicerchi, Shinichiro Inaba, MyPhuong T. Le, Makoto Miyazaki, Jason Glaser, Ricardo Correa‐Rotter, Marvin González-Quiroz, Aurora Aragón, Catharina Wesseling, Laura Gabriela Sánchez‐Lozada, Richard J. Johnson	2013	197
15	Urinary CD80 is elevated in minimal change disease but not in focal segmental glomerulosclerosis Kidney International ·Eduardo H. Garin, Wei Mu, John M. Arthur, Christopher J. Rivard, Carlos E. Araya, Michiko Shimada, Richard J. Johnson	2010	127
16	Different ways to die: cell death modes of the unicellular chlorophyte Dunaliella viridis exposed to various environmental stresses are mediated by the caspase-like activity DEVDase Journal of Experimental Botany ·Carlos Jiménez, Juan M. Capasso, Charles L. Edelstein, Christopher J. Rivard, L. Savarino, Sophia Y. Breusegem, Tomás Berl, Marı́a Segovia	2009	109
17	Expression of the Calcium-binding Protein S100A4 Is Markedly Up-regulated by Osmotic Stress and Is Involved in the Renal Osmoadaptive Response Journal of Biological Chemistry ·Christopher J. Rivard, Lewis M. Brown, Zhongya Liao, Arvid B. Maunsbach, Kaarina Pihakaski‐Maunsbach, Ana Andrés-Hernando, Juan M. Capasso, Tomás Berl	2007	25
18	Silencing and overexpression of the γ-subunit of Na-K-ATPase directly affect survival of IMCD3 cells in response to hypertonic stress American Journal of Physiology-Renal Physiology ·Juan M. Capasso, Christopher J. Rivard, Tomás Berl	2006	9
19	Evaluation of spray-drying methods for cellulase preservation M. Himmel, Constance Rosser, A.N. SMIRNOVA, Christopher J. Rivard, K. Grohmann, Charles D. Scott	1986	2
20	Isolation and Characterization of Methanomicrobium paynteri sp. nov., a Mesophilic Methanogen Isolated from Marine Sediments Applied and Environmental Microbiology ·Christopher J. Rivard, J. Michael Henson, Michael V. Thomas, Paul Smith	1983	26

About Christopher J. Rivard

Christopher J. Rivard is a scholar working on Nephrology, Building and Construction, Oncology, Transplantation and Pathology and Forensic Medicine, having authored 133 papers that have together received 6.7k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (20 papers), Lung Cancer Research Studies (19 papers), Anaerobic Digestion and Biogas Production (17 papers), Liver Disease Diagnosis and Treatment (17 papers), Biofuel production and bioconversion (16 papers), Diet, Metabolism, and Disease (15 papers), Alcohol Consumption and Health Effects (13 papers) and Cancer Immunotherapy and Biomarkers (12 papers). The work is most often cited by research in Nephrology (1.1k citations), Endocrinology, Diabetes and Metabolism (1.2k citations), Oncology (1.5k citations), Pathology and Forensic Medicine (700 citations) and Epidemiology (1.2k citations). Christopher J. Rivard has collaborated with scholars based in United States, Japan and China. Frequent co-authors include Richard J. Johnson, Miguel A. Lanaspa, Carlos A. Roncal-Jiménez, Laura Gabriela Sánchez‐Lozada, Christina Cicerchi, Tomás Berl, Takuji Ishimoto, Hui Yu, Nanxing Li and Juan M. Capasso. Their work appears in journals such as Applied Biochemistry and Biotechnology, Journal of Thoracic Oncology, American Journal of Physiology-Renal Physiology, PLoS ONE and Proceedings of the National Academy of Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact